Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative-Reference-Cited by-同舟云学术

Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative

Published:2018-06 Issue:22 Volume:97 Page:e10940
ISSN:0025-7974
Container-title:Medicine
language:en
Short-container-title:

Author:

Wang Kai,Jiang Guomin,Jia Zhongzhi,Zhu Xiaoli,Ni Caifang

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference16 articles.

1. Influence of hepatitis B virus reactivation on the recurrence of HBV-related hepatocellular carcinoma after curative resection in patients with low viral load;Sohn;J Viral Hepat,2015

2. Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers;Wong;J Clin Oncol,2010

3. Prevalence of hepatitis B in the southeast of China: a population-based study with a large sample size;Luo;Eur J Gastroenterol Hepatol,2011

4. Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis;Leng;ANZ J Surg,2016

5. Sur-vival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis;Lee;Clin Mol Hepatol,2016

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 5-FU promotes HBV replication through oxidative stress-induced autophagy dysfunction;Free Radical Biology and Medicine;2024-03

2. TACE versus TACE + entecavir versus TACE + tenofovir in the treatment of HBV associated hepatocellular carcinoma;BMC Cancer;2023-03-13

3. Efficacy of nucleos(t)ide analogues(NAs) in preventing virus reactivation in oncology patients with HBV infection after chemotherapy or surgery: A network meta-analysis;Frontiers in Oncology;2023-01-16

4. Peripartum management of tuberous sclerosis complex complicated by massive angiomyolipomas;Anaesthesia Reports;2022-07

5. KASL clinical practice guidelines for management of chronic hepatitis B;Clinical and Molecular Hepatology;2022-04-01